Webster R O, Lawrence D A
Immunology. 1979 Apr;36(4):659-70.
The cytophilic binding of immune complexes by peritoneal exudate cells (PEC) from adjuvant-stimulated guinea-pigs was studied using 125I-labelled guinea-pig IgG1, IgG2 and IgM antibodies to the dinitrophenyl (DNP) group. The influence of hapten density upon cytophilic activity was studied by the addition of DNP-conjugated antigens to antibody in 2-200 molar ratios of DNP:antibody. Only IgG2 binding was enhanced by immune complex formation, and the increased binding of IgG2 anti-DNP was dependent on the number of DNP determinants per antigen molecule. Cytophilic activity with epsilon-DNP-L-lysine (DNP-LYS), alpha,epsilon-di-DNP-L-lysine (DNP-LYS-DNP), or DNP1-8-BSA was no greater than that seen in the absence of hapten. Increased cytophilic binding was noted only with DNP20-41-BSA. The binding of IgG2 and IgG2 anti-DNP:DNP-bovine serum albumin (BSA) complexes was inhibited by monomeric IgG2. The relative cytophilic capacities of guinea-pig immunoglobulins appeared as follows: IgG greater than IgG1 greater than IgM. IgG1 and IgM binding of DNP conjugates did not enhance their cytophilic activity; therefore, IgG1 and IgM cytophilic binding to PEC was considered biologically insignificant. This investigation provides further evidence that cytophilic binding of immune complexes to macrophages is due to the co-operative action of multiple Fc sites rather than a conformational change in the IgG2 antibodies, and serum proteins, notably complement components, can alter the binding and/or phagocytosis of IgG2 anti-DNP:DNP-BSA complexes.
利用针对二硝基苯基(DNP)基团的125I标记的豚鼠IgG1、IgG2和IgM抗体,研究了佐剂刺激的豚鼠腹腔渗出细胞(PEC)对免疫复合物的嗜细胞性结合。通过以2 - 200的DNP:抗体摩尔比向抗体中添加DNP偶联抗原,研究了半抗原密度对嗜细胞活性的影响。只有IgG2的结合通过免疫复合物形成得到增强,并且IgG2抗DNP结合的增加取决于每个抗原分子上DNP决定簇的数量。用ε-DNP-L-赖氨酸(DNP-LYS)、α,ε-二-DNP-L-赖氨酸(DNP-LYS-DNP)或DNP1-8-BSA时的嗜细胞活性不高于无半抗原时的活性。仅在DNP20-41-BSA时观察到嗜细胞结合增加。IgG2和IgG2抗DNP:DNP-牛血清白蛋白(BSA)复合物的结合被单体IgG2抑制。豚鼠免疫球蛋白的相对嗜细胞能力如下:IgG大于IgG1大于IgM。DNP缀合物的IgG1和IgM结合并未增强其嗜细胞活性;因此,IgG1和IgM与PEC的嗜细胞结合被认为在生物学上无意义。这项研究进一步证明,免疫复合物与巨噬细胞的嗜细胞结合是由于多个Fc位点的协同作用,而非IgG2抗体的构象变化,并且血清蛋白,尤其是补体成分,可改变IgG2抗DNP:DNP-BSA复合物的结合和/或吞噬作用。